| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.05▲ | 8.24▲ | 8.21▲ | 7.70▲ | 8.11▲ |
| MA10 | 8.04▲ | 8.08▲ | 7.81▲ | 7.56▲ | 8.94▼ |
| MA20 | 7.53▲ | 7.71▲ | 7.70▲ | 8.09▲ | 8.88▼ |
| MA50 | 7.71▲ | 8.24▲ | 8.50▼ | 9.24▼ | 10.88▼ |
| MA100 | 9.12▼ | 9.10▼ | 8.95▼ | 9.04▼ | N/A |
| MA200 | 9.44▼ | 10.57▼ | 10.86▼ | 11.07▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.096▲ | 0.142▲ | 0.172▲ | 0.089▲ | -0.050▼ |
| RSI | 55.729▲ | 54.032▲ | 53.341▲ | 49.201▼ | 42.395▼ |
| STOCH | 83.333▲ | 95.020▲ | 92.456▲ | 70.988 | 27.697 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -22.672▲ | -72.984 |
| CCI | 70.757 | 71.819 | 86.449 | 75.935 | -90.800 |
|
Thursday, June 25, 2026 10:04 PM
Total non-dilutive funding awarded to eXoZymes is now almost $20 million, validating the scalable nature of the ...
|
|
Thursday, June 18, 2026 10:50 AM
XoZymes ( (EXOZ)) has provided an update. On June 17, 2026, Los Angeles-based eXoZymes Inc. announced the closing of an underwritten public offering of 330,575 units of common stock and warrants on ...
|
|
Wednesday, June 17, 2026 01:41 PM
LOS ANGELES, CA / ACCESS Newswire / June 17, 2026 / eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or "Company"), a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/06/26 | 8.04 | 8.24 | 7.27 | 8.24 | 19,337 |
| 26/06/26 | 7.785 | 8.03 | 7.21 | 8.03 | 8,479 |
| 25/06/26 | 7.585 | 7.9684 | 7.20 | 7.40 | 3,591 |
| 24/06/26 | 7.625 | 7.625 | 7.14 | 7.14 | 2,681 |
| 23/06/26 | 8.02 | 8.0958 | 7.70 | 7.70 | 3,829 |
| 22/06/26 | 7.95 | 8.21 | 7.10 | 8.18 | 7,864 |
| 18/06/26 | 6.5074 | 7.83 | 6.5074 | 7.83 | 19,889 |
| 17/06/26 | 8.21 | 8.21 | 6.33 | 6.33 | 17,576 |
| 16/06/26 | 7.795 | 7.795 | 7.358 | 7.42 | 2,301 |
| 15/06/26 | 7.675 | 7.80 | 7.35 | 7.35 | 1,562 |
|
|
||||
|
|
||||
|
|